Concord Medical Services Holdings Limited (NYSE:CCM) Short Interest Update

Concord Medical Services Holdings Limited (NYSE:CCM) was the target of a large increase in short interest in the month of May. As of May 15th, there was short interest totaling 7,483 shares, an increase of 134.9% from the April 30th total of 3,186 shares. Approximately 0.3% of the shares of the stock are short sold. Based on an average trading volume of 86,277 shares, the short-interest ratio is presently 0.1 days.

Concord Medical Services Trading Up 1.5%

Shares of CCM traded up $0.08 on Friday, reaching $4.98. The stock had a trading volume of 7,813 shares, compared to its average volume of 62,582. The firm has a 50-day moving average of $4.27 and a 200 day moving average of $4.13. The company has a debt-to-equity ratio of 1.33, a quick ratio of 0.46 and a current ratio of 0.48. Concord Medical Services has a twelve month low of $3.18 and a twelve month high of $10.77.

Concord Medical Services (NYSE:CCM) last released its quarterly earnings results on Wednesday, April 29th. The company reported ($1.08) earnings per share for the quarter.

Analyst Ratings Changes

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Concord Medical Services in a report on Tuesday. One analyst has rated the stock with a Sell rating, According to MarketBeat, Concord Medical Services currently has an average rating of “Sell”.

About Concord Medical Services

Concord Medical Services Holdings Limited is one of China’s leading providers of radiotherapy equipment and oncology services. The company specializes in supplying and operating advanced radiotherapy machines, including linear accelerators, computed tomography (CT) simulators and brachytherapy units, to public and private hospitals. Through its integrated service model, Concord Medical Services delivers treatment planning, machine maintenance and clinical support to enhance the precision and effectiveness of cancer therapies.

Founded in 1997 and headquartered in Beijing, Concord Medical Services has developed an extensive network of oncology centers across major cities and provinces in China.